INVENTIA
LIVE

Serial Number

79385808

Owner

Inventia Pty Ltd

Attorney

Robyn S. Lederman

Filing Date

Jul 14, 2023

Add to watchlist:

No watchlists yet
View on USPTO

INVENTIA Trademark

Serial Number: 79385808 • Registration: 8105499

INVENTIA is a trademark filed by Inventia Pty Ltd on July 14, 2023. The trademark is classified under Class 7 (Machinery), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Inventia Pty Ltd

Unit F901/7 Hunter Street

Entity Type: 99

Trademark Details

Filing Date

July 14, 2023

Registration Date

January 20, 2026

Published for Opposition

December 2, 2025

Goods & Services

Surgical robots, namely, robotic apparatus for medical or surgical purposes; surgical robots; surgical robots for medical purposes; medical apparatus for use in soft tissue repair, reconstruction of soft tissue deficiencies, regenerative surgery, plastic reconstructive surgery and wound healing in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research; structural parts and fittings therefor; none of the foregoing being in relation to oral or injectable therapies for the treatment of patient needs in the areas of fibrosis, lysosomal storage disorders and oncology, cardiometabolic diseases, liver diseases, metabolic disorders, obesity, diabetes, severe dyslipidemias, NASH, inflammatory diseases and autoimmune diseases

Scientific and technological services and research and design relating thereto, all in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research; industrial analysis, industrial research and industrial design services, all in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research; design and development of computer software; software as a service (SAAS) services, namely, hosting software for use by others in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research and to identify, select and print biomaterials for the purpose of experiments; providing online non-downloadable software for use by others in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research and to identify, select and print biomaterials for the purpose of experiments; computer support services, namely, computer programming and software installation, repair and maintenance services; scientific research services, specifically, analysis of statistical data for scientific research purposes; design of software; design and development of new products in the field of biological materials; visual design services in the nature of designing visual elements for print media; new product design services; scientific research relating to design in the field of 3D printing, bioprinting, cell printing, cell assembly and biomedical research; laboratory research in the field of biomedical research, bioprinting, cell printing, cell assembly and the creation and engineering of 3D cells and living tissues; biomedical research; cloud computing featuring software for use in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research and to identify, select and print biomaterials for the purpose of experiments; technical consultancy in the field of scientific research; scientific research in the field of soft tissue repair, reconstruction of soft tissue deficiencies, regenerative surgery, plastic reconstructive surgery, wound healing, drug discovery, genetics, dermatology and oncology; scientific research into the development of new products; technical support services, namely, troubleshooting in the nature of repair of medical equipment and diagnostic laboratory instruments and systems; providing online non-downloadable web-based computer software platforms for laboratory and diagnostic equipment information management, monitoring and analysis; providing information and online information regarding the foregoing; none of the foregoing being in relation to oral or injectable therapies for the treatment of patient needs in the areas of fibrosis, lysosomal storage disorders and oncology, cardiometabolic diseases, liver diseases, metabolic disorders (including obesity, diabetes, severe dyslipidemias, NASH), inflammatory diseases and autoimmune diseases

Laboratory robots; downloadable software for monitoring and controlling communication between computers and automated machine systems; downloadable software for operating and controlling 3D printers; downloadable operating software to control laboratory apparatus for fabrication of three dimensional (3D) engineered living tissues; downloadable software for the purpose of the manufacture of products by means of a 3D printer, including medical products; laboratory instruments and apparatus, namely, cell assembly apparatus for laboratory use for fabrication of three dimensional (3D) engineered living tissues; print heads for 3D printers and bioprinters; downloadable electronic publications, namely, pamphlets, brochures, journals, books, manuals, newsletters and booklets in the field of living tissue, tissue regeneration, 3D printing, cell printing, cell assembly and biomedical research; parts and fittings for all of the foregoing, namely, electronic control panels with digital displays for the control of three dimensional (3D) printers, printer cables, and ink cartridges, unfilled, for printers

3D printers; computerized printers for the generation of 3D shaped parts; machines, namely, 3D bioprinters for the printing of living cells and tissues or printing 3D cell structures; cartridges being parts of 3D printers for containing printing materials; cartridges being parts of 3D printers for containing bioprinting materials; printing cartridges being parts of 3D printers for containing biomaterials and reagents; printing cartridges being parts of 3D printers for containing bio-ink; robotic handling apparatus, namely, robotic handling apparatus and arms for industrial and commercial use; accessories and spare parts for three dimensional (3D) printers for the production of biological materials, namely, print heads for three dimensional (3D) printers; machines, namely, three dimensional (3D) printer for the printing of engineered living tissues; three dimensional (3D) printers; structural parts and fittings therefor

Data management; wholesale and retail store services for pharmaceutical, medical, scientific, laboratory and 3D printing consumables and supplies; online wholesale and retail store services featuring pharmaceutical, medical, scientific, laboratory and 3D printing consumables and supplies; administrative processing of purchase orders; order fulfillment services, namely, computerised stock ordering and purchasing; computerised data processing; compiling and analyzing statistics, data and other sources of scientific information for business purposes; computerised register management, namely, maintenance of registers for others

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 20, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 20, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 20, 2026 R.PR
LIMITATION OF GOODS RECEIVED FROM IB
Dec 25, 2025 LIMG
NOTIFICATION PROCESSED BY IB
Dec 11, 2025 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 2, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 2, 2025 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2025 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 26, 2025 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 25, 2025 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 31, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 27, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 27, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 27, 2025 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 6, 2025 OPNX
LIMITATION OF GOODS RECEIVED FROM IB
May 23, 2025 LIMG
NOTIFICATION OF FINAL REFUSAL EMAILED
May 22, 2025 GNFN
FINAL REFUSAL E-MAILED
May 22, 2025 GNFR
FINAL REFUSAL WRITTEN
May 22, 2025 CNFR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 20, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 20, 2025 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 15, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2025 TROA
LIMITATION OF GOODS RECEIVED FROM IB
Mar 28, 2025 LIMG
REFUSAL PROCESSED BY IB
Nov 23, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 4, 2024 RFCS
REFUSAL PROCESSED BY MPU
Nov 4, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 30, 2024 RFCR
NON-FINAL ACTION WRITTEN
Oct 29, 2024 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Oct 22, 2024 RFWR
NEW REPRESENTATIVE AT IB RECEIVED
Aug 30, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Aug 23, 2024 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 24, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 23, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 26, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 22, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 21, 2023 REPR